HOUGEN ELIZABETH L
SEC CIK 1074773 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| IONS | IONIS PHARMACEUTICALS INC | EVP, CFO, Fin | 92.8K | — | $22.52M | 29 | 2021-08-31 | 2026-03-16 |
Most active insiders at IONS, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Monia Brett P | CEO, Dir | — | $30.35M |
| 2 | HOUGEN ELIZABETH L | EVP, CFO, Fin | — | $21.12M |
| 3 | BENNETT C FRANK | EVP, CSO | — | $16.71M |
| 4 | Geary Richard S | EVP, Chief Development Off | — | $13.35M |
| 5 | O'NEIL PATRICK R. | GC, EVP CLO | — | $9.17M |
| 6 | Devers Shannon L. | EVP, Chief Human Resources Ofc | — | $8.66M |
| 7 | Swayze Eric | EVP Research | — | $7.51M |
| 8 | LOSCALZO JOSEPH | Dir | — | $7.09M |
| 9 | KLEIN JOSEPH III | Dir | — | $6.00M |
| 10 | WENDER JOSEPH H | Dir | — | $5.44M |
Transactions 29
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2026-03-18 | 2026-03-16 | IONS | IONIS PHARMACEUTICALS INC | HOUGEN ELIZABETH L | EVP, CFO, Fin | M - OptEx | $51.37 | +175.0K | 307.9K | +132% | +$8.99M |
| DM | 2026-03-18 | 2026-03-16+ | IONS | IONIS PHARMACEUTICALS INC | HOUGEN ELIZABETH L | EVP, CFO, Fin | S - Sale+OE | $72.43 | -225.2K | 92.8K | -71% | -$16.31M |
| 2026-02-02 | 2026-01-29 | IONS | IONIS PHARMACEUTICALS INC | HOUGEN ELIZABETH L | EVP, CFO, Fin | A - Grant | $0.00 | +13.6K | 139.9K | +11% | $0 | |
| 2026-02-02 | 2026-01-30 | IONS | IONIS PHARMACEUTICALS INC | HOUGEN ELIZABETH L | EVP, CFO, Fin | S - Sale | $83.24 | -6,988 | 132.9K | -5% | -$581.7K | |
| D | 2026-01-20 | 2026-01-16 | IONS | IONIS PHARMACEUTICALS INC | HOUGEN ELIZABETH L | EVP, CFO, Fin | S - Sale+OE | $75.22 | -12.9K | 126.3K | -9% | -$972.0K |
| D | 2026-01-20 | 2026-01-15 | IONS | IONIS PHARMACEUTICALS INC | HOUGEN ELIZABETH L | EVP, CFO, Fin | M - OptEx | $0.00 | +28.7K | 139.2K | +26% | $0 |
| D | 2025-10-01 | 2025-09-30 | IONS | IONIS PHARMACEUTICALS INC | HOUGEN ELIZABETH L | EVP, CFO, Fin | M - OptEx | $53.77 | +49.8K | 160.3K | +45% | +$2.68M |
| D | 2025-10-01 | 2025-09-30 | IONS | IONIS PHARMACEUTICALS INC | HOUGEN ELIZABETH L | EVP, CFO, Fin | S - Sale+OE | $65.26 | -49.8K | 110.5K | -31% | -$3.25M |
| 2025-02-03 | 2025-01-30 | IONS | IONIS PHARMACEUTICALS INC | HOUGEN ELIZABETH L | EVP, CFO, Fin | A - Grant | $0.00 | +4,138 | 112.0K | +4% | $0 | |
| 2025-02-03 | 2025-01-31 | IONS | IONIS PHARMACEUTICALS INC | HOUGEN ELIZABETH L | EVP, CFO, Fin | S - Sale | $32.44 | -1,523 | 110.5K | -1% | -$49.4K | |
| D | 2025-01-17 | 2025-01-15 | IONS | IONIS PHARMACEUTICALS INC | HOUGEN ELIZABETH L | EVP, CFO, Fin | M - OptEx | $0.00 | +23.9K | 116.8K | +26% | $0 |
| D | 2025-01-17 | 2025-01-16 | IONS | IONIS PHARMACEUTICALS INC | HOUGEN ELIZABETH L | EVP, CFO, Fin | S - Sale+OE | $32.81 | -8,870 | 107.9K | -8% | -$291.0K |
| A | 2024-09-04 | 2024-02-02 | IONS | IONIS PHARMACEUTICALS INC | HOUGEN ELIZABETH L | EVP, CFO, Fin | S - Sale | $49.54 | -2,162 | 92.9K | -2% | -$107.1K |
| 2024-02-02 | 2024-02-01 | IONS | IONIS PHARMACEUTICALS INC | HOUGEN ELIZABETH L | EVP, CFO, Fin | A - Grant | $0.00 | +4,140 | 95.0K | +5% | $0 | |
| 2024-02-02 | 2024-02-02 | IONS | IONIS PHARMACEUTICALS INC | HOUGEN ELIZABETH L | EVP, CFO, Fin | S - Sale | $49.54 | -2,125 | 92.9K | -2% | -$105.3K | |
| D | 2024-01-18 | 2024-01-17 | IONS | IONIS PHARMACEUTICALS INC | HOUGEN ELIZABETH L | EVP, CFO, Fin | S - Sale+OE | $50.42 | -8,683 | 90.9K | -9% | -$437.8K |
| D | 2024-01-18 | 2024-01-16 | IONS | IONIS PHARMACEUTICALS INC | HOUGEN ELIZABETH L | EVP, CFO, Fin | M - OptEx | $0.00 | +22.5K | 99.6K | +29% | $0 |
| D | 2024-01-02 | 2023-12-28 | IONS | IONIS PHARMACEUTICALS INC | HOUGEN ELIZABETH L | EVP, CFO, Fin | F - Tax | $50.50 | -43.8K | 77.1K | -36% | -$2.21M |
| D | 2024-01-02 | 2023-12-28 | IONS | IONIS PHARMACEUTICALS INC | HOUGEN ELIZABETH L | EVP, CFO, Fin | M - OptEx | $47.34 | +45.2K | 120.9K | +60% | +$2.14M |
| 2023-03-02 | 2023-02-28 | IONS | IONIS PHARMACEUTICALS INC | HOUGEN ELIZABETH L | EVP, CFO, Fin | J - Other | $30.52 | +163 | 75.7K | +0.2% | +$4,975 | |
| 2023-02-07 | 2023-02-06 | IONS | IONIS PHARMACEUTICALS INC | HOUGEN ELIZABETH L | EVP, CFO, Fin | S - Sale | $40.59 | -2,079 | 75.5K | -3% | -$84.4K | |
| 2023-02-07 | 2023-02-03 | IONS | IONIS PHARMACEUTICALS INC | HOUGEN ELIZABETH L | EVP, CFO, Fin | A - Grant | $0.00 | +4,140 | 77.6K | +6% | $0 | |
| D | 2023-01-19 | 2023-01-18 | IONS | IONIS PHARMACEUTICALS INC | HOUGEN ELIZABETH L | EVP, CFO, Fin | S - Sale+OE | $39.70 | -8,280 | 73.4K | -10% | -$328.7K |
| D | 2023-01-19 | 2023-01-17 | IONS | IONIS PHARMACEUTICALS INC | HOUGEN ELIZABETH L | EVP, CFO, Fin | M - OptEx | $0.00 | +23.2K | 81.7K | +40% | $0 |
| 2022-09-01 | 2022-08-31 | IONS | IONIS PHARMACEUTICALS INC | HOUGEN ELIZABETH L | EVP, CFO, Fin | J - Other | $28.97 | +202 | 58.6K | +0.3% | +$5,852 | |
| 2022-03-02 | 2022-02-28 | IONS | IONIS PHARMACEUTICALS INC | HOUGEN ELIZABETH L | EVP, CFO, Fin | J - Other | $28.37 | +384 | 58.4K | +0.7% | +$10.9K | |
| D | 2022-01-20 | 2022-01-18 | IONS | IONIS PHARMACEUTICALS INC | HOUGEN ELIZABETH L | EVP, CFO, Fin | F - Tax | $30.12 | -7,828 | 58.0K | -12% | -$235.8K |
| D | 2022-01-20 | 2022-01-18 | IONS | IONIS PHARMACEUTICALS INC | HOUGEN ELIZABETH L | EVP, CFO, Fin | M - OptEx | $0.00 | +22.1K | 65.8K | +50% | $0 |
| 2021-09-02 | 2021-08-31 | IONS | IONIS PHARMACEUTICALS INC | HOUGEN ELIZABETH L | EVP, CFO, Fin | J - Other | $33.80 | +166 | 43.8K | +0.4% | +$5,611 |
Purchase Sale Sale after option exercise All abbreviations